Drug
Iiv HD Nvxc19 Combination
Iiv HD Nvxc19 Combination: highest development phase Phase 3, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| IIV-HD + NVXC19 combination NCT07890454 | Phase 3 | Immunization |
Latest
No recent events.
Follow Iiv HD Nvxc19 Combination on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.